Fifth Third Bancorp
AMLX icon

Fifth Third Bancorp’s Amylyx Pharmaceuticals AMLX Stock Holding History

Fifth Third Bancorp’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.5K Buy
+755
New +$10.6K ﹤0.01% 3691

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Fifth Third Bancorp's AMLX Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in Amylyx Pharmaceuticals (AMLX) in Q1 2026: 755 shares worth $10.5K. The stake represents ﹤0.01% of the portfolio and ranks #3691 among its holdings.

171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

  • Fifth Third Bancorp held 755 shares of Amylyx Pharmaceuticals worth $10.5K as of Q1 2026.
  • Amylyx Pharmaceuticals was a new Fifth Third Bancorp position in Q1 2026.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #3691 holding.
  • 171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.